AKT1 and renal carcinoma: That seems to be particularly important in renal cancer, due to the frequent overproduction of proangiogenic and proinflammatory cytokines, which disrupts the angiogenic balance through the stimulation of the RAS/RAF/MEK/ERK and PI3 Kinase/AKT/mTOR signaling pathways [64].